BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33600700)

  • 1. Development and Testing of Thrombolytics in Stroke.
    Nikitin D; Choi S; Mican J; Toul M; Ryu WS; Damborsky J; Mikulik R; Kim DE
    J Stroke; 2021 Jan; 23(1):12-36. PubMed ID: 33600700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology Insight: recanalization with drugs and devices during acute ischemic stroke.
    Smith WS
    Nat Clin Pract Neurol; 2007 Jan; 3(1):45-53. PubMed ID: 17205074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study.
    Qureshi AI; Siddiqui AM; Suri MF; Kim SH; Ali Z; Yahia AM; Lopes DK; Boulos AS; Ringer AJ; Saad M; Guterman LR; Hopkins LN
    Neurosurgery; 2002 Nov; 51(5):1319-27; discussion 1327-9. PubMed ID: 12383381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recanalization therapies for acute ischemic stroke.
    Broderick JP
    Semin Neurol; 1998; 18(4):471-84. PubMed ID: 9932618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?
    Noser EA; Shaltoni HM; Hall CE; Alexandrov AV; Garami Z; Cacayorin ED; Song JK; Grotta JC; Campbell MS
    Stroke; 2005 Feb; 36(2):292-6. PubMed ID: 15625300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art reperfusion strategies for acute ischemic stroke.
    Cohen JE; Itshayek E; Moskovici S; Gomori JM; Fraifeld S; Eichel R; Leker RR
    J Clin Neurosci; 2011 Mar; 18(3):319-23. PubMed ID: 21256755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of thrombolysis and its clinical application in stroke.
    Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P
    J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical thrombectomy for acute ischemic stroke using the MERCI retriever and penumbra aspiration systems.
    Tenser MS; Amar AP; Mack WJ
    World Neurosurg; 2011 Dec; 76(6 Suppl):S16-23. PubMed ID: 22182267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular Treatment of Thrombosis and Embolism.
    Goktay AY; Senturk C
    Adv Exp Med Biol; 2017; 906():195-213. PubMed ID: 27664152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future.
    Balami JS; Chen R; Sutherland BA; Buchan AM
    CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):145-54. PubMed ID: 23394531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
    Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
    JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third generation thrombolytics for the treatment of ischemic stroke.
    Qureshi AI; Pande RU; Kim SH; Hanel RA; Kirmani JF; Yahia AM
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1729-32. PubMed ID: 12528307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke.
    Shah QA; Georgiadis A; Suri MF; Rodriguez G; Qureshi AI
    Neurocrit Care; 2007; 7(1):53-7. PubMed ID: 17657656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New thrombolytic drugs.
    Thomson A
    Aust N Z J Med; 1999 Jun; 29(3):433-5. PubMed ID: 10868516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.